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Abstract: Objectives - Sepsis is responsible for a substantial proportion of global childhood morbidity and
mortality. However, evidence demonstrates major inaccuracies in the use of the term ”sepsis” in clinical
practice, coding, and research. Current and previous definitions of sepsis have been developed using
expert consensus but the specific criteria used to identify children with sepsis have not been rigorously
evaluated. Therefore, as part of the Society of Critical Care Medicine’s Pediatric Sepsis Definition
Taskforce, we will conduct a systematic review to synthesize evidence on individual factors, clinical
criteria, or illness severity scores that may be used to identify children with infection who have or are
at high risk of developing sepsis-associated organ dysfunction and separately those factors, criteria, and
scores that may be used to identify children with sepsis who are at high risk of progressing to multiple
organ dysfunction or death. Data Sources - We will identify eligible studies by searching the following
databases: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials. Study Selection
- We will include all randomized trials and cohort studies published between January 1, 2004, and March
16, 2020. Data Extraction - Data extraction will include information related to study characteristics,
population characteristics, clinical criteria, and outcomes. Data Synthesis - We will calculate sensitivity
and specificity of each criterion for predicting sepsis and conduct a meta-analysis if the data allow. We
will also provide pooled estimates of overall hospital mortality. Conclusions - The potential risk factors,
clinical criteria, and illness severity scores from this review which identify patients with infection who
are at high risk of developing sepsis-associated organ dysfunction and/or progressing to multiple organ
dysfunction or death will be used to inform the next steps of the Pediatric Sepsis Definition Taskforce.
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Objectives: Sepsis is responsible for a substantial proportion of global 
childhood morbidity and mortality. However, evidence demonstrates major 
inaccuracies in the use of the term “sepsis” in clinical practice, coding, and 
research. Current and previous definitions of sepsis have been developed 
using expert consensus but the specific criteria used to identify children 
with sepsis have not been rigorously evaluated. Therefore, as part of the 
Society of Critical Care Medicine’s Pediatric Sepsis Definition Taskforce, 
we will conduct a systematic review to synthesize evidence on individual 
factors, clinical criteria, or illness severity scores that may be used to 
identify children with infection who have or are at high risk of developing 
sepsis-associated organ dysfunction and separately those factors, crite-
ria, and scores that may be used to identify children with sepsis who are 
at high risk of progressing to multiple organ dysfunction or death.
Data Sources: We will identify eligible studies by searching the fol-
lowing databases: MEDLINE, Embase, and the Cochrane Central 
Register of Controlled Trials.
Study Selection: We will include all randomized trials and cohort 
studies published between January 1, 2004, and March 16, 2020.
Data Extraction: Data extraction will include information related to study 
characteristics, population characteristics, clinical criteria, and outcomes.
Data Synthesis: We will calculate sensitivity and specificity of each 
criterion for predicting sepsis and conduct a meta-analysis if the 
data allow. We will also provide pooled estimates of overall hospital 
mortality.
Conclusions: The potential risk factors, clinical criteria, and illness 
severity scores from this review which identify patients with infection 
who are at high risk of developing sepsis-associated organ dysfunction 
and/or progressing to multiple organ dysfunction or death will be used 
to inform the next steps of the Pediatric Sepsis Definition Taskforce.
Key Words: childhood; infection; mortality; organ dysfunction; sepsis; 
septic shock
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nfection accounts for almost one third of emergency depart-
ment visits (1) and 40% of hospitalizations (2) and 25% of 
deaths in children globally (3). Although the majority of 
children have mild disease and recover quickly, almost 5 million 
children worldwide progress to life-threatening organ dysfunction 
and even death (4). The concept of sepsis has been traditionally 
used to characterize children with infection that manifest higher 
severity of disease with signs indicating presence of a systemic 
response to infection (5). The World Health Organization reso-
lution on sepsis (6) stipulates quality improvement and public 
health interventions at local, national, and international level to 
reduce the burden of sepsis. Although recent meta-analyses indi-
cate that sepsis is responsible for a substantial proportion of global 
childhood deaths from infection (7), evidence demonstrates sub-
stantial variability in the definition of sepsis and lack of precision 
when applying the term in clinical practice, coding, and research 
(8) which may lead to underestimation of the burden of sepsis.
The 1991 consensus conference on sepsis (5), and subsequent 
adult and pediatric sepsis definitions (9) have operationalized the 
disease definition using systemic inflammatory response syn-
drome (SIRS) (5) in the presence of presumed or proven infection 
as a requirement to meet criteria for sepsis, severe sepsis, or sep-
tic shock (9–11). SIRS was conceptualized as the body’s systemic 
response to an insult (e.g., infection) and included age-specific 
abnormalities in two or more of the following variables: 1) body 
temperature; 2) heart rate; 3) respiratory rate; or 4) WBC count. 
However, these criteria were nonspecific and do not reliably dis-
criminate children with infections on a more severe trajectory or 
a higher risk of mortality (12). Ideally, sepsis criteria should meet 
both the need for sensitive early recognition as well as for specific 
separation of severe from mild infections. In the absence of a gold 
standard test to diagnose sepsis, the 2005 International Pediatric 
Sepsis Consensus Conference used expert opinion to provide age-
specific cutoffs for SIRS criteria and operationalized definitions 
of organ failures (9). Since then, numerous studies have provided 
insights into the epidemiology, recognition, and treatment of sep-
sis in children (13–15). However, the diagnostic value of specific 
criteria to identify children with sepsis has never been rigorously 
evaluated.
In the 2016 update to the sepsis definition in adult patients 
(Sepsis-3), the Society of Critical Care Medicine (SCCM) and 
European Society of Intensive Care Medicine Sepsis Definitions 
Task Force conducted a systematic review of reported criteria used 
to identify adults with septic shock (11). This review only assessed 
hemodynamic criteria (hypotension, vasopressors, and hypoper-
fusion) and excluded pediatric studies, randomized controlled 
trials, and studies of specific pathogens and populations, thereby 
limiting its applicability to pediatrics. Furthermore, results of 
adult trials cannot be automatically generalized to the pediatric 
population because of significant differences in epidemiology 
(16), mortality rates (17), underlying diseases (18), disease-spe-
cific outcomes (13, 19), and differing results of septic shock trials 
in adults and children (20, 21).
Therefore, SCCM convened the Pediatric Sepsis Definition 
Taskforce in June 2019 to assess, develop, and validate criteria for 
the identification of sepsis in children. The Taskforce recognizes 
the need to assess both criteria for recognition of children with 
possible sepsis and for identification of sepsis leading to poor 
outcomes such as multiple organ failure or death. As part of this 
process, the Taskforce will conduct a systematic review, a survey, a 
Delphi process and a data-driven derivation and validation exer-
cise. The goals of this systematic review are to synthesize evidence 
on individual factors, clinical criteria, or illness severity scores that 
may be used to identify children with infection who have or are at 
high risk of developing sepsis-associated organ dysfunction and 
separately to synthesize evidence on those factors, criteria, and 
scores that may be used to identify children with sepsis who are at 
high risk of progressing to multiple organ dysfunction or death.
OBJECTIVES
To determine whether 1) in children greater than or equal to 37 
weeks postgestational age to less than 18 years with suspected or 
confirmed infection are individual factors, physiologic variables, 
laboratory tests, and illness severity scores associated with the 
development of sepsis, severe sepsis, or septic shock and 2) in chil-
dren greater than or equal to 37 weeks postgestational age to less 
than 18 years with sepsis, severe sepsis, or septic shock are indi-
vidual factors, physiologic variables, laboratory tests, and illness 
severity scores associated with development of new or progressive 
multiple organ dysfunction (NPMODS) and/or mortality.
MATERIALS AND METHODS
This protocol follows the Preferred Reporting Items for Systematic 
Review and Meta-Analysis Protocols guidelines (PROSPERO), is 
registered in the international prospective register of systematic 
reviews (November 12, 2019; PROSPERO—42019147932) and 
is funded, organized, and reviewed by SCCM. The multinational 
and multidisciplinary scientific panel responsible for development 
of the systematic review protocol includes subject matter experts 
from across the globe that were selected for the Pediatric Sepsis 
Definition Taskforce.
Eligibility Criteria
All cohort studies (prospective or retrospective), randomized and 
quasi-randomized trials published between January 1, 2004, and 
March 16, 2020, will be included. The search will be updated as 
needed such that the final submitted article will contain all articles 
published up to the previous 6 months. The start date of January 
2004 was chosen to allow identification of studies published fol-
lowing the operational definition from the Pediatric Consensus 
Conference Sepsis Definition which was initiated in 2004 and 
published in 2005 (9). Literature before 2004 often lacked refer-
ence to specific sepsis criteria and as such, we anticipated it would 
be hard to reliably extract associations between sepsis criteria and 
outcomes prior to 2004. Studies with fewer than 50 children with 
sepsis, septicemia, severe sepsis, or septic shock will be excluded 
as they are unlikely to be adequately powered to describe criteria 
for recognition of possible sepsis or criteria for sepsis leading to 
multiple organ failure or death and are likely to have a high risk 
of bias due to their small sample size (22). Abstract only publica-
tions, case studies, narrative reviews, surveys, and study protocols 
will also be excluded.
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Population. The study population is defined as children greater 
than or equal to 37 weeks postgestational age to less than 18 years 
with suspected or confirmed infection presenting to any health-
care facility. Areas within the hospital where these patients are 
identified could include PICU/ICU/neonatal ICU, high depen-
dency units, emergency departments, pediatric wards (general 
or specialized), or outpatient settings (e.g., oncology clinics). We 
will not include studies primarily focusing on adult patients with 
co-recruitment of adolescents or studies of premature infants. In 
addition, we will not include studies of full-term newborns that 
have never left hospital as the current criteria for organ dysfunc-
tion have not been validated in neonates during the first days of 
life (23). Specifically, Pao
2
, creatinine, and bilirubin thresholds 
used in organ dysfunction scores do not apply in the first days 
of life due to physiologic adaptation; in addition, serum lactate 
levels following delivery may reflect placental circulation rather 
than ongoing problems in the newborn (24). All study popula-
tions (cardiac surgery, oncology, etc.) and pathogens (viruses, 
fungi, bacteria, parasites, etc.) will be included.
Exposure. The exposures we will consider in this systematic 
review will be 1) suspected or confirmed infection with any 
pathogen (in children who have or are at high risk of developing 
sepsis-associated organ dysfunction) and 2) sepsis, septicemia, 
severe sepsis, or septic shock (in children at high risk of pro-
gressing to multiple organ dysfunction or death). Suspected or 
confirmed infections require either a diagnostic code of infec-
tion or the combination of a healthcare provider decision to treat 
with any length of antimicrobials and an attempt to obtain sam-
ples of body fluid cultures (e.g., blood, urine, cerebrospinal fluid, 
or other cultures). The article may define sepsis, severe sepsis, 
septicemia, or septic shock by any criteria provided the specific 
criteria used are explicitly stated.
Comparison. The comparators will be patient criteria (individ-
ual factors, signs and symptoms, physiologic variables, laboratory 
tests) or illness severity scores (such as Pediatric Index of Mortality 
[25], Pediatric Logistic Organ Dysfunction [26], Pediatric Risk 
of Mortality [27], SIRS [9], pediatric Sequential [Sepsis-related] 
Organ Failure Assessment [28], and quick Sequential [Sepsis-
related] Organ Failure Assessment [29]) assessed from 24 hours 
before diagnosis of sepsis/septicemia/septic shock until discharge 
from an acute-care setting. All versions of the listed illness sever-
ity scores will be included. Potential criteria to be included in our 
systematic review are detailed in Table 1; additional criteria will 
be added as dictated by the literature search. Studies focusing pri-
marily on criteria that are only available on a research basis (e.g., 
gene-expression data) will not be eligible.
Outcomes. The primary outcomes for 1) articles describing cri-
teria to identify children with infection who have or are at high 
risk of developing sepsis-associated organ dysfunction are the 
diagnostic categories of sepsis, septicemia, severe sepsis, or sepsis 
shock. The primary outcomes for 2) articles describing criteria to 
identify children with sepsis who are at high risk of progressing to 
multiple organ dysfunction or death is development of NPMODS 
or healthcare facility mortality. Secondary outcomes for both 
types of articles include PICU admission, PICU mortality, 28-day 
mortality, PICU and hospital length of stay, and development 
of NPMODS (30). Although we acknowledge the importance 
of longer-term and quality of life-related outcomes, we will not 
be considering them for this review. We will assess the associa-
tion of individual criteria and scores listed in Table 1 with each of 
the described outcomes in children with suspected or confirmed 
infection or sepsis, septicemia, severe sepsis, or septic shock. 
Studies must report on at least one of the primary or secondary 
outcomes in order to be included.
TABLE 1. Potential Criteria to Identify in Eligible Studies
Organ System Physiologic Variables/Laboratory Measurements/Scores
Cardiac Heart rate, blood pressure (systolic, diastolic, mean, pulse pressure), central capillary refill, inotropes and Vasotropic-Inotropic 
Score (26), fluid boluses, central venous pressure, central and mixed venous oxygen saturation, shock index










 ratio, oxygen 
saturation/FIO
2
 ratio (27), oxygenation index, oxygen saturation index, noninvasive and invasive ventilation (including high-
flow nasal cannula), extracorporeal membrane oxygenation
Neurologic Pupillary dilatation, Alert, Verbal, Pain, Unresponsive scale, Glasgow Coma Scale, irritability/lethargy, new seizures, Blantyre 
Coma Score
Metabolic Base excess, pH (arterial, venous, or capillary as available), hyper/hypoglycemia, lactate (26, 28–31)
Endocrine Thyroid hormone, vitamin A or vitamin D levels
Hepatic Bilirubin, aspartate aminotransferase/alanine aminotransferase, albumin
Renal Urine output, urea, creatinine, renal replacement therapy, Risk, Injury, Failure, Loss of kidney function, and End-stage kidney 
disease criteria
Inflammatory Temperature (ideally core), WBC (including absolute neutrophil count, lymphocyte counts, and percentage of immature cells), 
erythrocyte sedimentation rate,  C-reactive protein, procalcitonin, bacterial, viral, and fungal cultures, polymerase chain reaction
Hematologic Platelet count, international normalized ratio, fibrinogen, D-dimer, activated prothrombin time, protein C, antithrombin III
All Pediatric Index of Mortality, Pediatric Logistic Organ Dysfunction, Pediatric Risk of Mortality, systemic inflammatory response 
syndrome, pediatric Sequential (Sepsis-related) Organ Failure Assessment, quick Sequential (Sepsis-related) Organ Failure 
Assessment
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Data Sources
We will identify eligible studies by searching the following data-
bases: MEDLINE (including Epub Ahead of Print), Embase, and 
the Cochrane Central Register of Controlled Trials. We will hand 
search references of the primary studies and systematic reviews 
for relevant studies. Data from abstracts or conference proceed-
ings will not be searched.
Search Strategy
We will develop a search strategy with the help of a health infor-
mation specialist (Appendix 1, Supplemental Digital Content 1, 
http://links.lww.com/CCX/A179). In addition to age, Medline 
MeSH search terms will include “sepsis,” “septicemia,” and “septic 
shock.” We will consider adding the following limiting variables 
“epidemiology,” “criteria,” “characteristics,” “variables,” “diagnosis,” 
“definition,” “decision rule,” “predictors,” and “recognition” if the 
original search yields greater than 10,000 articles. We will also use 
sentinel articles identified by members of the Systematic Review 
Working Group to validate the inclusiveness of the search strategy. 
There will be no language restrictions for the search.
Study Selection and Screening Process
The titles from the combined search will be downloaded and 
screened using a previously validated crowdsourcing platform 
Insight Scope (31). Citations will be screened for eligibility based 
on title and abstract, and full text using Insight Scope (www.insight-
Scope.ca). Insight Scope is a web-based systematic review platform 
designed to facilitate citation screening, full-text upload, and con-
flict resolution. At each screening level, citations will be screened 
by two independent reviewers, and conflicts will be resolved by a 
member of the Systematic Review Working Group using the con-
flict resolution function. Insight Scope members who are interested 
in contributing to citation screening for this review will complete a 
test set of 100 citations and must achieve a sensitivity of 80% before 
they are given access to the project. At least 5–10 true positives 
will be purposely included in the test set. The test set will be cre-
ated by the principal investigator (K.M.) and verified by one other 
Systematic Review Working Group member (L.S.) before the proj-
ect is posted to recruit reviewers. Each title will be screened by two 
reviewers using the predetermined eligibility criteria. Titles elimi-
nated by both reviewers will be rejected and the remaining titles 
moved to full-text screening. Each remaining full-text article will be 
screened by two members of the Systematic Review Working Group 
for inclusion in the final set of articles for data extraction. Conflicts 
will be resolved by discussion or a third member of the Systematic 
Review Working Group if consensus is not reached during the dis-
cussion. Kappa scores on the level of agreement reached between 
reviewers at each stage of screening will be reported.
Data Extraction and Management
Data from all included full-text articles will be extracted by two 
Systematic Review Working Group reviewers per citation using a 
Research Electronic Data Platform (REDCap) platform (32) hosted 
at the Children’s Hospital of Eastern Ontario Clinical Research 
Unit. Conflicts will be resolved by discussion or by a member of 
the Systematic Review Working Group if consensus cannot be 
reached. Data extraction will include information related to study 
characteristics (i.e., title, authors, year of publication, country, lan-
guage, journal, study design, sample size, and inclusion/exclusion 
criteria); population characteristics (age, sex, admission diagnosis, 
level of care available, location of the admission within the hospi-
tal/clinic, disease classification of population studied, and patient 
comorbidities); exposure (pathogen, source, community-acquired 
vs hospital-acquired infection, or sepsis as per Centers for Disease 
Control and Prevention criteria [33], specific definition of sepsis 
used); clinical criteria (Table 1); and outcomes (PICU admission, 
28-d mortality, PICU mortality, PICU and/or hospital length of 
stay, and NPMODS). Studies may report varying thresholds of 
“normal” for laboratory data such as serum glucose and bicarbon-
ate; these thresholds will be documented in our data abstraction 
form. The authors will be contacted to obtain missing data on study 
methods or patient level data needed for computation of sensitiv-
ity and specificity of dichotomous outcomes. We will not contact 
authors for patient level data for calculation illness severity scores 
if these were not reported in the original article.
Risk of Bias in Individual Studies
We will assess the quality of selected articles using the Quality in 
Prognosis Studies tool for assessment of risk of bias in observa-
tional studies (34). We will perform a subgroup analysis to deter-
mine if there is a credible subgroup effect in which case, we would 
only include the low risk of bias studies in the final meta-analysis.
Data Synthesis and Analysis
We will summarize data on study characteristics, outcomes, and 
other related variables, criteria/scores reported as well as qual-
ity assessment using tables, graphs, and narrative summaries. 
Continuous outcomes will be summarized using mean and sds or 
medians with interquartile ranges as appropriate. Binary outcomes 
will be summarized using frequencies and percentages. We will 
construct a two-by-two table for each criterion identified in the 
included studies and will add 0.5 to all cells if any of the cells are 
zero. For each criterion, we will calculate its sensitivity and specific-
ity for predicting sepsis, multiple organ failure, or death and report 
the corresponding 95% CIs. We will also calculate the likelihood 
ratios for the presence (positive likelihood ratio) or absence (nega-
tive likelihood ratio) of each criteria/score and pretest and post-
test probabilities of the outcome (sepsis, multiple organ failure, or 
death). For interventional studies, only the outcomes in the usual 
care arm of the study will be included in these estimates.
When a criterion is assessed in four or more studies, we will 
perform a meta-analysis of diagnostic accuracy studies to cal-
culate pooled estimates of sensitivity and specificity as well as 
provide the pooled area under the receiver operating character-
istic curve. We will use a hierarchical random-effects bivariate 
logistic regression model, which accounts for heterogeneity as 
well as the correlation between sensitivity and specificity. We 
will examine sources of heterogeneity, including differences 
in methodology, setting, patient populations as well as differ-
ences in clinical presentations (e.g., different diagnosis or dis-
ease prognosis). Statistical heterogeneity will be assessed and 
reported using a chi-square test and the I2 statistic. It is likely 
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that there will be significant heterogeneity between studies and 
we will therefore pool results when studies are considered com-
parable (I2 value < 40%) using a random-effects meta-analysis. 
We will perform subgroup analyses with respect to age, diag-
nostic category (e.g., oncology, severe acute malnutrition), com-
munity- versus hospital-acquired infections, healthcare setting 
(low vs high resource), and other relevant factors with the aim 
of providing more precise pooled estimates. We will present the 
results using sensitivity-specificity coupled forest plots as well as 
pooled receiver operating characteristic curves.
We will provide pooled estimates of overall hospital mortal-
ity and multiple system organ failure using a random-effects 
meta-analysis. Relative risk will be used as an effect measure in 
the meta-analysis. If data are available, we will also conduct meta-
analysis to provide pooled estimates on sepsis-related mortality, 
PICU admission, PICU mortality, 28-day mortality, and PICU 
and hospital length of stay. We will report 95% CIs and provide 
graphical visualization of the results with forest plots. We will also 
consider subgroup analyses if we have adequate numbers of stud-
ies and/or patients within the included studies. All analyses will be 
performed the R statistical software (R Foundation for Statistical 
Computing, Vienna, Austria).
It is possible that different thresholds might have been used in 
calculating sensitivity and specificity, leading to high level of het-
erogeneity across the studies. As such, we will categorize stud-
ies with respect to similarity in thresholds used and only pool 
the estimates from similar studies. We will choose a threshold 
used in the majority of the studies and contact authors to receive 
individual-level data for the rest of the studies to calculate sensi-
tivity and specificity. For studies with missing thresholds, we will 
impute missing data based on information provided in similar 
studies. Similarly, some studies report summary measures of the 
continuous outcome (e.g., mean and sd of lactate levels) rather 
than provide sensitivity and specificity by dichotomizing the 
outcomes. For such studies, we will request patient level data, 
and if provided, will calculate sensitivity and specificity based on 
a threshold used in the majority of the studies.
DISCUSSION
The goals of this systematic review are to synthesize evidence on 
individual factors, clinical criteria, and/or illness severity scores 
for the recognition of possible sepsis, sepsis, septicemia, and sep-
tic shock in children with suspected or documented infections 
and to synthesize evidence on factors, criteria, and scores that 
may be used to identify children with sepsis who are at high risk 
of progressing to multiple organ dysfunction or death. As this is 
a broad topic, we anticipate that there will be a large number of 
eligible citations. However, we will minimize the risk of miss-
ing key citations by hand searching references of primary studies 
and systematic reviews for relevant studies as well as soliciting 
sentinel articles from the Systematic Review Working Group.
It is important to note that the objective of this systematic 
review is to determine the evidence behind possible criteria previ-
ously used in the literature to identify patients with sepsis, sep-
ticemia, and septic shock and not to validate a new definition of 
sepsis. The determination of which variables have been correlated 
with the clinically important outcomes outlined in this system-
atic review is an important step toward the development and vali-
dation of new criteria for pediatric sepsis by the Pediatric Sepsis 
Definition Taskforce of SCCM.
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